Related Experiment Video

Updated: Aug 11, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Cerebrovascular disease and dementia

Velandai Srikanth1, Michael M Saling, Amanda G Thrift

  • 1Menzies Research Institute, Hobart, Australia. velandai.srikanth@utas.edu.au

Drugs of Today (Barcelona, Spain : 1998)
|February 14, 2006
PubMed

Insights

Cerebrovascular disease is linked to dementia, a common disabling condition in older adults. Understanding this link may help prevent and treat dementia more effectively.

Area of Science:

  • Neurology
  • Gerontology
  • Epidemiology

Background:

  • Cerebrovascular disease and dementia are highly prevalent, disabling disorders in the elderly.
  • Previous research suggests a potential causal relationship between cerebrovascular disease and dementia.
  • Clarifying this association is crucial for developing effective dementia prevention and treatment strategies.

Purpose of the Study:

  • To synthesize current research on the association between cerebrovascular disease and dementia.
  • To explore the underlying mechanisms linking vascular factors to cognitive decline.
  • To identify potential avenues for future research in this field.

Main Methods:

  • Review of epidemiological studies.
  • Analysis of clinical data.
  • Integration of basic science research findings.

Main Results:

  • Certain manifestations of cerebrovascular disease are established causal factors for dementia.
  • The exact nature and extent of the causal contribution of other cerebrovascular factors remain controversial.
  • Lack of understanding hinders the identification of dementia phenotypes predominantly caused by cerebrovascular disease.

Conclusions:

  • Further examination of vascular factors and dementia associations is warranted.
  • The interplay between aging, vascular health, and cognitive decline requires more investigation.
  • Integrating basic and clinical science is essential for clarifying these complex relationships.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...